Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 844 clinical trials
Guardant360 Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer

The purpose of this study is to observe the routine clinical care of patients who have been diagnosed with breast cancer and have undergone Guardant360 testing.

breast cancer
cancer
  • 0 views
  • 05 Aug, 2020
Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer

This is a multi-center, observational study designed to explore the regulatory mechanism of palbociclib correlative pathways in therapeutic process of breast cancer, employing next generation sequencing (NGS) on DNA and RNA. This study also monitor the clonal evolution of genes by tracing the ctDNA.

hormone therapy
breast cancer
metastasis
her2/neu-negative breast cancer
hair thinning
  • 0 views
  • 16 Feb, 2024
  • 1 location
reatment Standards and Outcomes of Patients With ER/PR Positive HER2-negative Metastatic Breast Cancer

To capture the treatment patterns and clinical characteristics of patients with ER/PR positive, HER2-negative MBC in Greece

stage iv breast cancer
HER2
breast cancer
cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprint/Blueprint Test

This study prospectively included 150 breast cancer patients (30 patients in the first stage and 120 patients in the second stage) who were treated with the commonly used neoadjuvant chemotherapy recommended by NCCN, received surgical treatment after neoadjuvant chemotherapy, and evaluated the efficacy according to the surgical pathological response.Based on …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Concordance of the IHC4 Score Performed in Local or Central Laboratory to Endopredict in ER+/HER2- Breast Cancer

Retrospective observational, multicentric study assessing the immunohistochemistry (IHC) based test IHC4 score in infiltrating early breast cancer: comparison of the score performed in local laboratory vs in a central laboratory and concordance with a molecular gold standard classifier (EndoPredict).

immunohistochemistry
HER2
cancer
er-positive breast cancer
invasive breast cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
Lumpectomy Specimen Margin Evaluation With Tomography and Structured Light Imaging

The purpose of this study is to test a new surgical imaging system called "Structured Light Imaging (SLI)." This system is designed to examine tissue removed during breast cancer surgery to see whether the tissue's edges contain cancer. The current standard of practice is to remove the breast tumor tissue …

core needle biopsy
breast-conserving surgery
invasive breast cancer
breast tumor
lumpectomy
  • 0 views
  • 16 Feb, 2024
  • 1 location
Bringing of PET-TDM FDG in the Determination of the Characteristics of Primary Mammary Tumors TrIple Negatives

"Triple Negative" breast cancers are a heterogeneous group characterized by the absence of hormone receptors to estrogen, progesterone and the absence of expression or amplification of the HER-2 gene.

metastasis
immunohistochemistry
triple-negative breast cancer
triple negative breast cancer
estrogen
  • 0 views
  • 16 Feb, 2024
  • 1 location
Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk

This study seeks to develop an explanatory framework for breast MRI utilization to inform future interventions. The Health Services Utilization Model (HSUM) will guide the selection of specific participant-level factors for examination, including predisposing characteristics (knowledge, health/cultural beliefs), enabling resources (social support, cost/insurance coverage), and perceived need (perceived susceptibility, provider …

magnetic resonance imaging of breast
BRCA1
mammogram
BRCA1/2
screening mammography
  • 0 views
  • 16 Feb, 2024
  • 2 locations
Clinical Database of Safe Personalized Adjuvant Breast Radiotherapy Based on Individual Radiosensitivity

Severe but also moderate toxicities after curative-intent radiotherapy (RT), such as a poor cosmetic outcome following breast cancer can have a negative impact on quality of life and a marked effect on subsequent psychological outcome. Nevertheless, current practice standards commonly prescribe radiation dose and volume without regard to individual radiosensitivity.

hypofractionated radiation therapy
radiotherapy to breast
immunostimulant
brachytherapy
luminal a breast cancer
  • 0 views
  • 16 Feb, 2024
  • 1 location
Health Economy Register

CANKADO helps patients and their physicians regarding therapy management by a standardized documentation procedure and, if needed, direct feedback to patients by the integrated Pro-React system. GeRA includes patients undergoing systemic therapy for breast cancer with access to CANKADO. The trial is based on questionnaires that are answered by patients …

systemic therapy
cancer care
breast cancer
cancer
  • 0 views
  • 16 Feb, 2024
  • 10 locations